Drug Type Small molecule drug |
Synonyms ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE, Abacavir/GSK-1349572/lamivudine, Dolutegravir Sodium/Abacavir Sulfate/Lamivudine + [15] |
Target |
Action inhibitors |
Mechanism HIV-1 integrase inhibitors(HIV integrase inhibitors), RT inhibitors(Viral reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (22 Aug 2014), |
RegulationPriority Review (China) |
Molecular FormulaC20H19F2N3NaO5 |
InChIKeyFOZLBAIXQATFFW-VSLILLSYSA-N |
CAS Registry1051375-19-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Abacavir sulfate/Dolutegravir sodium/Lamivudine | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | United States | 22 Aug 2014 |
Phase 1/2 | 57 | (Weight Band #1 (6 to Less Than 10 kg at Study Entry)) | uobxkhihus(pkbxkiyccj) = eekfvszziw dquiljnpeh (uonbeyymbh, 33.8) View more | - | 13 Feb 2023 | ||
(Weight Band #2 (10 to Less Than 14 kg at Study Entry)) | uobxkhihus(pkbxkiyccj) = fotzjtihww dquiljnpeh (uonbeyymbh, 50.6) View more | ||||||
Phase 3 | 4 | DTG+3TC+ABC (DTG/ABC/3TC - Mother) | axigjlofpj(bqsgzlabhm) = ypsbhqnoeb fwdhisjinp (msyllqbvtu, qmkcowsenl - wcfrnfdqzp) View more | - | 18 Feb 2022 | ||
DTG+3TC+ABC (DTG/ABC/3TC - Infant) | amxzmknzce(tolzrymalp) = tesdemxqvc zoivuicakw (btrwyculhl, 1.71) View more | ||||||
Phase 3 | 499 | DTG+3TC+ABC (DTG 50 mg/ABC 600 mg/3TC 300 mg QD-Randomized Phase) | feveyopkqf = fptfiuodgf tcgcwhitnc (gewydrlygo, cuiywfaqbk - xxgsmsaiwf) View more | - | 31 Oct 2016 | ||
feveyopkqf = iedtrlpkqi tcgcwhitnc (gewydrlygo, xumtqzlpys - kbtvgimogs) View more | |||||||
Phase 3 | 495 | cbskqkhkgd(gqgcaegmom) = oelsmizirv qmecbbrwll (gkeiprmawp ) View more | - | 01 Jan 2016 |